The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Health-related quality of life (QoL) in randomized phase III trials in oncology: Association between results of QoL, results of primary endpoint and drug approval.
 
Chiara Paratore
No Relationships to Disclose
 
Rocco Schiavone
No Relationships to Disclose
 
Clizia Zichi
No Relationships to Disclose
 
Andrea Caglio
No Relationships to Disclose
 
Teresa Gamba
No Relationships to Disclose
 
Sebastiano Bombaci
No Relationships to Disclose
 
Giorgio Vellani
No Relationships to Disclose
 
Laura Marandino
Speakers' Bureau - Gilead Sciences; Merck
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Janssen
 
Francesco Perrone
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb Italy; GlaxoSmithKline; Incyte; Incyte; Lilly; Lilly; MSD Oncology; Pfizer
Research Funding - Incyte (Inst); Merck (Inst); Pfizer (Inst); Tesaro/GSK (Inst)
 
Massimo Di Maio
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Eisai; Janssen; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Eisai; Janssen; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Research Funding - GlaxoSmithKline (Inst); Tesaro (Inst)